You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LAGE-1

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Sep 15, 2023

Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Jul 5, 2023

Prostate Cancer, Bladder Cancer, NSCLC Trial in New York, Houston (NY-ESO-1 Plasmid DNA Cancer Vaccine)

Completed
Has Results
  • Prostate Cancer
  • +4 more
  • NY-ESO-1 Plasmid DNA Cancer Vaccine
  • New York, New York
  • +1 more
Oct 3, 2022

Select Advanced Solid Tumors Trial in Canada, United Kingdom, United States (IMCnyeso)

Terminated
Has Results
  • Select Advanced Solid Tumors
  • Aurora, Colorado
  • +11 more
Mar 9, 2022

Cancer, Tumor Trial in Frankfurt (NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51)

Completed
Has Results
  • Cancer
  • Neoplasm
  • NY-ESO-1b peptide plus CpG 7909 and Montanide® ISA-51
  • Frankfurt, Germany
    Krankenhaus Nordwest
Oct 3, 2022

Tumors Trial in Worldwide (Letetresgene autoleucel (lete-cel, GSK3377794), Fludarabine, Cyclophosphamide)

Active, not recruiting
  • Neoplasms
  • Letetresgene autoleucel (lete-cel, GSK3377794)
  • +2 more
  • Duarte, California
  • +36 more
Oct 28, 2022

Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Buffalo (biological, drug, other)

Completed
  • Fallopian Tube Carcinoma
  • +2 more
  • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2021

Type 1 Diabetes Trial in France, Germany, United Kingdom (MDI, AHCL)

Active, not recruiting
  • Type 1 Diabetes
  • MDI
  • AHCL
  • Besançon, France
  • +13 more
Dec 17, 2021

Tumors Trial (GSK3377794, Pembrolizumab, Fludarabine)

Withdrawn
  • Neoplasms
  • (no location specified)
Oct 26, 2019

Diabetes, Type 1 Trial in Worldwide (Accu-Chek® Solo micropump system, mylife™ OmniPod® Insulin Management System, Multiple

Completed
Has Results
  • Diabetes Mellitus, Type 1
  • Accu-Chek® Solo micropump system
  • +2 more
  • Feldkirch, Austria
  • +20 more
Aug 19, 2021

Unresectable or Metastatic Melanoma Trial in Australia, United States (Ipilimumab, NY-ESO-1 Protein Vaccine, NY-ESO-1 OLP4

Terminated
Has Results
  • Unresectable or Metastatic Melanoma
  • Ipilimumab
  • +3 more
  • New York, New York
  • +4 more
Oct 3, 2022

Prostate Cancer, Prostatic Tumors Trial in Boston (PROWESS)

Not yet recruiting
  • Prostate Cancer
  • Prostatic Neoplasms
  • PROWESS
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Feb 22, 2023

Lung Cancer, Non-Small Cell, Tumors Trial in Nashville, Madrid (Tumor biopsy)

Recruiting
  • Lung Cancer, Non-Small Cell
  • Neoplasms
  • Tumor biopsy
  • Nashville, Tennessee
  • +1 more
Aug 11, 2022

Type 1 Diabetes Trial in United States (MiniMed 780G System)

Recruiting
  • Type 1 Diabetes
  • MiniMed 780G System
  • Palo Alto, California
  • +16 more
Jan 24, 2023

Type 2 Diabetes Trial in Nanjing (Mulberry Twig Alkaloid Tablet, Canagliflozin)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Nanjing, China
    Jianhua Ma
May 3, 2023

Soft Tissue Sarcoma Trial in Guangzhou (TAEST16001 cells)

Active, not recruiting
  • Soft Tissue Sarcoma
  • TAEST16001 cells
  • Guangzhou, Guangdong, China
    Xing Zhang
Dec 13, 2022

Fallopian Tube Cancer, Ovarian Cancer, Peritoneal Cavity Cancer Trial in Buffalo, New York (ALVAC(2)-NY-ESO-1(M)/TRICOM vaccine,

Completed
Has Results
  • Fallopian Tube Cancer
  • +2 more
  • ALVAC(2)-NY-ESO-1(M)/TRICOM vaccine
  • Sargramostim
  • Buffalo, New York
  • +1 more
Sep 21, 2018

Synovial Sarcoma Trial in New York (ipilimumab)

Terminated
Has Results
  • Synovial Sarcoma
  • ipilimumab
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jun 23, 2021

Transitional Cell Carcinoma Trial in New York (TICE®-strain BCG, NY-ESO-1 protein, sargramostim)

Completed
Has Results
  • Transitional Cell Carcinoma
  • TICE®-strain BCG
  • +2 more
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Oct 3, 2022

Multiple Myeloma Trial in Duarte, Baltimore (Treatment with NY-ESO-1c259-modified T cells)

Terminated
Has Results
  • Multiple Myeloma
  • Treatment with NY-ESO-1c259-modified T cells
  • Duarte, California
  • +1 more
Jan 8, 2019

Tumor Antigen Expression Profiling and HLA Typing for

Recruiting
  • Solid and Hematological Malignancies
    • Duarte, California
    • +34 more
    Aug 23, 2022

    Small Fiber Neuropathy, Diabetes Trial in Worldwide (BIIB074, Placebo)

    Terminated
    • Small Fiber Neuropathy
    • Diabetes Mellitus
    • Byala, Bulgaria
    • +96 more
    Apr 30, 2021

    Type 2 Diabetes, High Blood Pressure Trial in Dallas (Polypill)

    Not yet recruiting
    • Type 2 Diabetes
    • High Blood Pressure
    • Dallas, Texas
      UT Southwestern Medical Center
    Nov 21, 2023

    Tumors Trial in Miami, Tampa, Houston (letetresgene autoleucel (GSK3377794), Cyclophosphamide, Fludarabine)

    Completed
    Has Results
    • Neoplasms
    • letetresgene autoleucel (GSK3377794)
    • +2 more
    • Miami, Florida
    • +2 more
    Aug 10, 2021

    COPD Trial in Rahim Yar Khan (Active cycle of breathing technique, Autogenic drainage)

    Not yet recruiting
    • Chronic Obstructive Pulmonary Disease
    • Active cycle of breathing technique
    • Autogenic drainage
    • Rahim Yar Khan, Punjab, Pakistan
      Sheikh Zayed Hospital,
    Jun 26, 2023